Please select the option that best describes you:

Does a transperineal approach to prostate biopsy change your treatment plan compared to transrectal?  

For example, transperineal biopsies may capture a higher volume of disease. Should this change risk stratification compared to transrectal biopsies? Is ">50% of cores" still the relevant metric? Conversely, transperineal biopsies may increase uncertainty about proximity of disease to the base of the prostate depending on how the pathologist reads the slide.



Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more

Answer from: Radiation Oncologist at Community Practice
Sign in or Register to read more